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Abstract
Interleukin-4 Induced Gene 1 (IL4I1) was first described as a B cell IL4-inducible gene and is highly expressed in primary mediastinal B cell lymphomas. We established stable HEK293 clones expressing human and mouse IL4I1 to examine their biochemical properties and function. Both proteins were secreted into the culture medium and we observed the secretion of endogenous human IL4I1 (hIL4I1) protein in a mediastinal lymphoma B cell line, MedB-1. We showed that IL4I1 has L amino-acid oxidase activity, optimal at physiological pH and primarily directed towards phenylalanine. Immunohistochemical analysis of secondary lymphoid organs showed staining of germinal center macrophages and inflammatory myeloid cells. In vitro, functional enzyme was highest in mature dendritic cells (DC), suggesting a role in antigen presenting cell-T lymphocyte cross-talk. Indeed, hIL4I1 inhibited the proliferation of CD3-stimulated T lymphocytes with a similar effect on CD4 + and CD8 + T cells. In contrast, memory T cells were more strongly affected by hIL4I1
and its catabolite H Altogether these data suggest IL4I1 as a new immunomodulatory enzyme produced by DC.
only.
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Introduction
Interleukin-4 (IL4) is the master cytokine for T helper type 2 (Th2) lymphocyte differentiation and function. Along with its important role in B lymphocyte stimulation by T helper cells in germinal centers of secondary lymphoid organs, it also regulates the growth and function of many different cell types of the immune system 1 . IL4 transcriptional effects are primarily mediated by the signalization and transcription factor 6 (STAT6) which is responsible for the induction and repression of multiple target genes 2 .
An immediate-early IL4-inducible gene called Interleukin Four Induced Gene 1 (FIG1/IL4I1) has first been described in the mouse 3 and subsequently characterized in human B cells 4 . IL4I1
mRNA expression is restricted to lymphoid tissues, with the highest levels found in lymph nodes and spleen 4, 5 . IL4 activated murine B cells express IL4I1 within 2 hours of stimulation. We have demonstrated that high levels of expression of this gene are characteristic of Primary Mediastinal Large B cell Lymphoma (PMBL), a specific subtype of diffuse large B cell lymphoma 5 . The high expression of IL4l1 by PMBL may result from the constitutive activation of STAT6 in these tumors 6 .
Both human and mouse IL4I1 mRNA sequences encode a protein containing a putative signal peptide indicative of potential secretion and a large central domain, highly homologous to flavin-containing amino acid oxidases 3, 4 . While sharing high similarity over the majority of the sequence (547 amino acids over 567 of the human), the human and mouse proteins diverge substantially at their C-terminal region 4 . The IL4I1 protein shares the highest similarity with proteins presenting L-amino acid oxidase (LAAO) activity, such as snake venom LAAO 7, 8 and mouse milk LAAO 9 . Recently, Mason et al have demonstrated that mouse IL4I1 (mIL4I1) possesses an LAAO activity towards aromatic amino acids. The enzyme was mostly active at acidic pH, in contrast to other known members of the LAAO family, and its expression was restricted primarily to lysosomes 10 .
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In this work, we have characterized the biochemical properties of the human protein and have compared them to those of the mouse enzyme. We have analyzed IL4I1 expression in secondary lymphoid tissues and in vitro in different cells of the immune system and investigated the possible role of hIL4I1 in T cell regulation. Most interestingly, the human enzyme was expressed, secreted and active in dendritic cells (DC) and able to inhibit T lymphocyte proliferation in vitro by a mechanism associated with a temporary decrease in T Cell Receptor (TCR) complex ζ chain expression. This decrease was dependent on the enzymatic production of H 2 O 2 .
Materials and Methods
Reagents -Chemical and cell culture reagents were purchased from Sigma Aldrich (St Quentin Fallavier, France) and GIBCO (Invitrogen, Cergy Pontoise, France) respectively. Human catalase was from Calbiochem (Darmstadt, Germany). Antibodies against CD3 (OKT3), TCRζ-PE (TIA-2) and myc (9E10) were purchased from eBioscience (San Diego, CA, USA), Immunotech (Beckman Coulter, Marseille, France) and Oncogene (Merck, Darmstadt, Germany) respectively. Magnetic microbeads coated with anti-human CD3, CD4, CD8, CD19, CD45RA and CD45RO antibodies and LS separation columns were purchased from Miltenyi Biotec (Bergisch Gladbach, Germany). IL-4, GM-CSF, TNFα, and IFNγ were purchased from R&D Systems (Abingdon, UK); LPS, PGE 2 and poly-IC from Sigma. Soluble CD40 trimeric ligand (CD40L) was kindly provided by Immunex (Seattle, WA, USA).
Plasmids -The full length 1.7 kb cDNA of hIL4I1 (GenBank accession number NM_152899) without the termination codon was obtained by PCR with the following primers (5'-ACAGCGGGAATTCTG-ATGGCCCCATTGGCCCTGCACCTCC-TCGTC-3'; 5'-CGTGACCTCGAGCATGCGA-GGTCCTCGTGTG-3') from the MedB-1 reverse transcribed cDNA and inserted into EcoRI and XhoI sites of pcDNA-mycHis3.1 (Invitrogen). The full length hIL4I1 cDNA contained a silent mutation (serine 547: AGC>AGT). An E481A-hIL4I1 mutant was generated using the Gene Tailor Site-Directed Mutagenesis System (Invitrogen) with the following primers: 5'-CGCATCTACTTTGCCGGCGCCCACACCGCCTAC-3' and 5'-GCCGGCAAAGTA-GATGCGGCCATAAGGGAC-3'. The mouse cDNA (GeneBank accession number NM_010215) was generated by PCR from mouse spleen reverse transcribed cDNA with the following primers: 5'- Stable HEK clones expressing IL4I1 were maintained in complete DMEM (10% heat inactivated fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin and 10 µ g/ml streptomycin) supplemented with 1.2mg/ml G418 (mouse and E481A-hIL4I1 mutant) or 50µg/ml blasticidin and 200µg/ml zeocin (wt hIL4I1), respectively, at 37°C in 5% CO 2 . Expression in T-Rex 293 clones was induced by the addition of 1µg/ml tetracycline. The SU-DHL-4 cell line was obtained from DSMZ (Braunschweig, Germany). The MedB-1 cell line has been described previously 11 .
Adherent Peripheral Blood Mononuclear Cells (PBMC) obtained from healthy donors after informed consent were differentiated into macrophages as in 12 and into immature DC (iDC) using GM-CSF and IL4 as previously described 13 . Mature dendritic cells (mDC) were obtained by 24 h incubation with different stimulating cocktails: 10 ng/ml TNFα + 3 µg/ml PGE 2 , 1.5 µg/ml CD40L with or without 1000 UI/ml IFNγ, 20 ng/ml LPS or 10 µg/ml poly-IC. B lymphocytes from tonsils and T lymphocytes from PBMC were obtained using anti-CD19 and anti-CD3 antibody-coated microbeads respectively, according to the manufacturer's instructions.
Antibody preparation -A polyclonal antibody against a peptide (SQDWKAERSQDPFEKC) in the Nterminal region was developed in rabbit and affinity purified against the same peptide by PickCell Laboratories BV (Amsterdam, Netherlands).
Protein preparation -For Western blot analysis, cells were lysed as previously described 6 , the proteins separated using SDS-PAGE or 7% Tris-acetate NUPAGE gels (Invitrogen), and transferred onto polyvinylidene difluoride membranes (Millipore, St Quentin en Yvelines, France). Revelation only.
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SU-DHL-4 and Med-B1 cell derived extracts were immunoprecipitated using the anti-IL4I1 antibody prior to Western Blot analysis.
For LAAO activity, cells recovered in PBS containing complete mini protease inhibitors (Roche, Meylan, France) were submitted to four cycles of freezing and thawing. After centrifugation at 13000g for 10 min, the soluble fraction was collected. The protein concentration was determined using the Biorad protein assay (Marnes-la-Coquette, France), with bovine serum albumin as standard.
Protein purification -His-tagged IL4I1 protein was purified from 10 ml of conditioned media from IL4I1-producing HEK cells using 1 ml of Ni-NTA agarose beads (Qiagen, Courtaboeuf, France). As a control, the purification procedure was performed on HEK cells transfected with the control pcDNA4-TO-mycHis (mock-beads). In order to exclude an artifact due to the conditions of protein overexpression, we looked for endogenous hIL4I1 expression in the PMBL-derived cell line MedB-1, previously shown to express high levels of hIL4I1 mRNA 5 ( fig. 1C) . No hIL4I1 was detected in control (non mediastinal) B cell lymphoma line SU-DH-L4. Importantly, the protein was detectable both in MedB-1 cell lysates and in the culture medium, implying that hIL4I1 is naturally secreted.
Measurement of LAAO activity -
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Human IL4I1 has an LAAO activity. As mouse IL4I1 has been reported to have an L-amino acid oxidase (LAAO) activity 10 , we tested the human protein for this activity. Significant LAAO activity was constantly detected both in cell extracts and in the culture supernatant of hIL4I1-HEK cells induced with tetracycline ( fig. 2A) For 4A ). These results were confirmed using purified hIL4I1 bound to agarose nickel beads (hIL4I1-beads) with 51.3 ± 10.7 % inhibition at the highest bead dose (mean ± SD of 4 experiments) as compared to proliferation in the presence of control beads (mock-beads). This inhibition was dependent on the amount of hIL4I1-beads used ( fig. 4B ).
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To investigate whether this hIL4I1 inhibitory effect required the direct interaction between hIL4I1 and T cells, we repeated the experiment with the beads placed in transwells. Under these conditions, we still observed inhibition of T cell proliferation ( fig. 4C) . A similar inhibition was achieved after a short (3 h) incubation with the beads in transwells (46.9 ± 16.2% inhibition, mean ± SD of 5 experiments), suggesting that most of the effect of hIL4I1 takes place during this short initial period. All subsequent experiments described were thus conducted on cell populations incubated with the enzyme covered beads in transwells.
We wondered whether some T cell populations were more sensitive to the anti-proliferative effect of only.
Discussion
In this work, we have characterized both human and mouse IL4I1 as secreted Lphenylalanine oxidases. Human and mouse IL4I1 present 79% identity over the majority of the molecule, while they share less than 11% identity in the C-terminal region 3 . Not only is this region much shorter in human, but it also has a different amino acid composition that changes its overall theoretical isoelectric point. These differences led us to characterize the human enzyme and to use the mouse protein as the reference. However, when stably over-expressed in HEK293 cells both human and mouse IL4I1 displayed similar biochemical properties. First, in accordance with the presence of a signal peptide, both were detected in the culture medium. Secretion was confirmed in another transfection model (F.C. unpublished data) and also in the PMBL-derived cell line MedB-1 and in mDC which naturally expressed high levels of IL4I1. Thus, like all LAAO enzymes described thus far, IL4I1 is secreted 9, 17 . Second, IL4I1 preferentially hydrolyzed L-phenylalanine and its activity was not restricted to acidic pH, being also active at a pH approaching neutrality.
Surprisingly, some of these results differed from data published by Mason and collaborators for the mouse enzyme, although we used the same experimental conditions to test the enzymatic activity 10 . In particular these authors did not find mIL4I1 to be secreted into the medium. However, they resembles IDO + cells distribution in secondary lymphoid tissues 21 . Also as IDO and ASEI, i) our results obtained using the transwell system and the inactive mutant form of hIL4I1 clearly showed that T lymphocyte proliferation was sensitive to the enzymatic activity of hIL4I1; ii) hIL4I1 is highly expressed by antigen presenting cells, with the highest levels found in mature DC. In mouse myeloid cells, Th1 cytokines induce IDO and iNOS2 and Th2 cytokines, such as IL4 and IL13 are potent inducers of ASEI, while both participate in concomitant induction of the two enzymes in MDSC 22, 23, 24 . We suggest that IL4I1, which is induced by IL4 3 , represents another member of this family of immunoregulatory enzymes. Under our culture conditions, DC were derived from donor monocytes using IL4 which could have acted synergistically with LPS to allow the secretion of active enzyme in mature DC. Indeed, a similar two step stimulation by PGE2 and TLR ligands is required by mature DC for functional IDO production 25 . Very recent microarray data have shown increased mRNA expression of IL4I1 in tumour-induced mouse MDSC, indicating that IL4I1 may participate in the negative feedback regulation of T cell activation by this heterogenous population of alternatively activated myeloid cells 24 .
For While the enzyme is probably functionally active inside the cell, it is highly compartmentalized, restricted to vesicles ( fig. 3B and data not shown) where it is likely to be physically separated from its substrate, and hence metabolically inactive. In addition, it is possible that HEK293 cells may be resistant to the effects of H 2 O 2 and other IL4I1 catabolites and/or phenylalanine deprivation upon its secretion. However, other cells such as primary T lymphocytes may lack these protective mechanisms. Indeed, donor T cell proliferation was significantly inhibited in the presence of purified hIL4I while the growth of the transformed T cell line Jurkat, was not affected (data not shown).
While CD4 + and CD8 + T cells displayed similar sensitivity to hIL4I1, the proliferation of memory T cells was more strongly inhibited than that of naïve T cells. Memory T lymphocytes were also more sensitive to the presence of H 2 O 2 and phenylpyruvate than naïve T lymphocytes. These results, obtained with H 2 O 2 , are in accordance with a previous report 16 , whereas to date phenylpyruvate is only known for its toxicity towards neural cells 28 . However, the effects of H 2 O 2 were observed at micromolar doses, while those of phenylpyruvate required millimolar amounts and thus are less likely to be compatible with a physiological effect.
Depending on the length of exposure, H 2 O 2 has been reported to have multiple effects on T cells. Short exposure to H 2 O 2 decreases TCRζ chain expression and tyrosine phosphorylation ultimately resulting in the suppression of antigen-specific T-cell proliferative responses 15 and cytokine secretion 29 without affecting viability, while prolonged treatment with H 2 O 2 induces T-cell apoptosis 16 . In our experimental setting we observed a transient decrease in TCRζ chain only.
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In conclusion, we have demonstrated for the first time that human IL4I1 is a secreted Lphenylalanine oxidase expressed by antigen presenting cells that is able to inhibit TCRζ chain expression and T lymphocyte proliferation via H 2 O 2 production. We propose that it is a new member 
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